making news with our
portfolio companies
Published FDA Pivotal Studies Find DermaSensor has 96% Sensitivity and Cuts Physician’s Missed Skin Cancers by Half
Published in the Journal of Primary Care and Community Health, the joint FDA pivotal studies demonstrated the performance and benefits of the hand-held, non-invasive, optical spectroscopy device in point-of-care skin lesion evaluation.
MIMOSA Diagnostics completes latest raise to accelerate north american commercialization
MIMOSA Diagnostics raises additional funds to support continued commercialization and growth.
New technology introduced to help Parkinson's patients walk
80% of Parkinson's patients suffer from a symptom called "freezing of gait." It’s when people suddenly lose the ability to take a step.